Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population

Environmental and Molecular Mutagenesis

Volumn 30, Issue 2, 1997, Pages 184-195

  Topinka, J ^a,d   Binkova B ^a   Mrackova G ^a   Stavkova Z ^a   Peterka, V ^a   Benes I ^b   Dejmek, J ^a   Lenicek J ^c   Pilcik T ^a   Sram R J ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b District Institute of Hygiene   (Czech Republic)

^c Regional Institute of Hygiene   (Czech Republic)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Air pollution; DNA adducts; GSTM1; Human placenta; Metabolic genotyping; NAT2

Indexed keywords

ACYLTRANSFERASE; ENVIRONMENTAL CHEMICAL; GLUTATHIONE TRANSFERASE;

ADULT; AIR POLLUTION; ARTICLE; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PLACENTA; POPULATION EXPOSURE; SMOKING;

ADOLESCENT; ADULT; AIR POLLUTANTS; ARYLAMINE N-ACETYLTRANSFERASE; ASCORBIC ACID; CZECH REPUBLIC; DNA ADDUCTS; FEMALE; FETAL BLOOD; GLUTATHIONE TRANSFERASE; HUMANS; PLACENTA; POLYCYCLIC HYDROCARBONS, AROMATIC; PREGNANCY; RURAL POPULATION; SMOKING; URBAN POPULATION; VITAMIN A; VITAMIN E;

NICOTIANA TABACUM;

EID: 0030850659     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1997)30:2<184::AID-EM11>3.0.CO;2-9     Document Type: Article

References (49)

1. Autrup H, Vestergaard AB, Okkels H (1995): Transplacental transfer of environmental genotoxins: Polycyclic aromatic hydrocarbon-albumin in non-smoking women, and the effect of maternal GSTM1 genotype. Carcinogenesis 16:1305-1309.
2. Bartsch H, Hietanen E (1996): The role of individual susceptibility in cancer burden related to environmental exposure. Environ Health Perspect 104(Suppl 3):569-577.
3. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW (1993): Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85:1159-1164.
4. Binková B, Lewtas J, Míšková I, Leníček J, Šrám R (1995). DNA adducts and personal air monitoring of carcinogenic polycyclic aromatic hydrocarbons in an environmentally exposed population. Carcinogenesis 16:1037-1046.
5. Binková B, Lewtas J, Míšková I, Rossner P, Černá M, Mračková G, Peterková K, Mumford J, Meyer J, Šrám R (1996): Biomarkers studies in the Northern Bohemia. Environ Health Perspect 104 (Suppl 3):591-597.
6. Caporaso N, Landi MT, Vineis P (1991): Relevance of metabolic polymorphisms to human carcinogenesis: Evaluation of epidemiologic evidence. Pharmacogenetics 1:14-19.
7. Doll R, Peto R (1981): "The Causes of Cancer: Quantitative Estimates of Avoidable Risks in the United States Today." Oxford, UK: Oxford University Press.
8. Driskell WJ, Neese JW, Bryant CC, Bashor MM (1982): Measurement of vitamin A and vitamin E in human serum by high-performance liquid chromatography. J Chromatog 231:439-444.
9. EPA (1984): "Methods for Determination of Toxic Organic Compounds in Ambient Air." Research Triangle Park, NC: EPA publication no 600/4-84-041.
10. Everson RB, Randerath E, Santella R, Cefalo RC, Avitts TA, Randerath K (1985): Detection of smoking-related covalent DNA adducts in human placenta. Science 231:54-56.
11. Everson RB, Randerath E, Santella RM, Avitts TA, Weinstein IB, Randerath K (1988):Quantitative association between DNA damage in human placenta and maternal smoking and birth weight. J Natl Cancer Inst 80:567-576.
12. Gallagher JE, Everson RB, Lewtas J, George M, Lucier GV (1994): Comparison of DNA adduct levels in human placenta from polychlorinated biphenyl exposed women and smokers in which CYP1A1 levels are similarly elevated. Teratogen Carcinogen Mutagen 14:183-192.
13. Gottlieb K, Manchester DK (1986): Twin study methodology and variability in xenobiotic placental metabolism. Teratogen Carcinogen Mutagen 6:253-263.
14. Green JL, Pan YHL, Reed GA (1991): Mutagenicity of benzo(a)pyrene bay-region sulfonafes. Carcinogenesis 12:1359-1362.
15. Green JL, Jones BC, Reed GA (1994): Effects of sulfite on the uptake and binding of benzo(a)pyrene diol epoxide in cultured murine respiratory epithelial cells. Environ Health Perspect 102:216-220.
16. Grinberg-Funes RA, Singh VN, Perera FP, Bell DA, Young TL, Dickey C, Wang LW, Santella RM (1994): Polycyclic aromatic hydrocarbon DNA adducts in smokers and their relationship to micronutrient levels and glutathione-S-transferase M1 genotype. Carcinogenesis 15:2449-2454.
17. Gupta RC (1984): Non-random binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci USA 81:6943-6947.
18. 32P-postlabeling analysis of aromatic carcinogen adducts. Cancer Res 45:5656-5662.
19. Hayashi S, Watanabe J, Kawajiri K (1992): Genetic susceptibility to lung cancer analyzed in terms of combined genotypes of P450 1A1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 83:866-870.
20. Hirvonen A, Husgvafel-Pursianen K, Antilla S, Vainio H (1994): Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis 15:813-815.
21. Hou SM, Lambert B, Hemminki K (1995): Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis 16:1913-1917.
22. IARC (1984): Evaluation of the carcinogenic risk of chemicals to humans: Polynuclear aromatic compounds. IARC Monogr. 34:101-131.
23. Idle JR, Armstrong M, Boddy AV, Boustead C, Cholerton S, Cooper J, Daly AK, Ellis J, Gregory W, Hadidi H, Hofer C, Holt J, Leathart J, McCracken N, Monkman SC, Painter JE, Taber H, Walker D, Yule M (1992): The pharmacogenetics of chemical carcinogenesis. Pharmacogenetics 2:246-258.
24. Kato R, Yamazoe Y (1987): Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates. Jpn J Cancer 78:297-311.
25. Kirlin WG, Ogolla F, Andrews AF, Trinidad A, Ferguson RJ, Yerokun T, Mpezo M, Hein DW (1991): Acetylator genotype-dependent expression of arylamine N-acetyltransferase in human colon cytosol from non-cancer and colorectal cancer patients. Cancer Res 51:549-555.
26. Ladero JM, Gonzales JF, Benitez J, Vargas E, Fernandez MJ, Baki W, Diaz-Rubio M (1991): Acetylator polymorphism in human colorectal carcinoma. Cancer Res 51:2098-2100.
27. Manchester DK, Weston A, Choi JS, Trivers GE, Fennessey PV, Quintana E, Farmer PB, Mann DL, Harris CC (1988): Detection of benzo(a)pyrene diol epoxide-DNA adducts in human placenta. Proc Natl Acad Sci USA 85:9243-9247.
28. 32P-postlabeling analysis of human placental DNA known to contain benzo[a]pyrene diol epoxide adducts. Carcinogenesis 11:553-559.
29. Manchester DK, Bowman ED, Parker NB, Caporaso NE, Weston A (1992): Determinants of polycyclic aromatic hydrocarbons-DNA adducts in human placenta. Cancer Res 52:1499-1503.
30. Marchand LL, Sivaraman L, Franke AA, Custer LJ, Wilkens LR, Lau AF, Cooney RV (1996): Predictors of N-acetyltransferase activity: Should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies. Cancer Epidemiol Biomark Prev 5:449-455.
31. Minchin RF, Kadlubar FF, Ilett KF (1993): Role of acetylation in colorectal cancer. Mutat Res 290:35-42.
32. Nakachi K, Imai K, Hayashi S, Kawajiri K (1993): Polymorphisms of the CYP 1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53:2994-2999.
33. Nielsen PS, dePater N, Okkels H, Autrup H (1996): Environmental air pollution and DNA adducts in Copenhagen bus drivers: Effect of GSTM1 and NAT2 genotypes on adduct levels. Carcinogenesis 17:1021-1027.
34. Pasanen M, Pelkonen O (1994): The expression and environmental regulation of P-450 enzymes in human placenta. Crit Rev Toxicol 24:211-229.
35. Pasanen M, Stenback F, Park SS, Gelboin HV, Pelkonen O (1988): Immunohistochemical detection of human placental cytochrome P-450-associated mono-oxygenase system inducible by maternal smoking. Placenta 9:267-275.
36. 32P-Assay of adducts in white blood cells and placentas of pregnant women: Lack of residential wood combustion-related adducts but presence of tissue-specific endogenous adducts. Teratogen Carcinogen Mutagen 10:373-384.
37. Santella RM, Perera FP, Young TL, Zhang YJ, Chiamprasert S, Tang D, Wang LW, Beachman A, Lin JH, DeLeo A. (1995): Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tartreated patients and controls and their relationship to glutathione S-transferase genotype. Mutat Res 334:117-124.
38. Sepkovic DV, Haley MJ, Axelrad CM, Shigematsu A, La Voie EJ (1986): Short-term studies on the in vivo metabolism of N-oxides of nicotine in rats. J Toxicol Environ Health 18:205-214.
39. Shields PG, Bowman ED, Harrington AM, Doan VT, Weston A (1993): Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res 53:3486-3492.
40. Šrám R (1993): The impact of air pollution on the health in Northern Bohemia. Air Pollut Epidemiol Rep 12:132-139.
41. Šrám R, Beneš I, Binková B, Dejmek J, Horstman D, Kotěšovec F, Otto D, Perreault SD, Rubeš J, Selevan SG, Skalík I, Stevens RK, Lewtas J (1996): Teplice Program: The impact of air pollution on human health. Environ Health Perspect 104(Suppl 4).
42. Stevens R, Pinto J, Mamane Y, Ondov J, Abdulraheem M, Al-Majed N, Sadek M, Cofer W, Ellenson W, Kellog R (1993): Chemical and physical properties of emissions from Kuwaiti oil fires. Water Sci Technol 27:223-233.
43. Van Vunakis H, Gjika HB, Langone JJ (1987): Radioimmunoassay for nicotine and cotinine. WHO Int Agency Res Cancer 9:317-330.
44. Vineis P, Martone T (1995): Genetic-environmental interactions and low-level exposure to carcinogens. Epidemiology 6:455-457.
45. Vineis P, Bartsch H, Caporaso N, Harrington A, Kadlubar FF, Landi MT, Malaveille C, Shields PG, Skipper P, Talaska G, Tannenbaum SR (1994): Genetically based N-acetyltransterase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 369:154-156.
46. Watts R, Lewtas J, Stevens R, Hartlage T, Pinto J, Williams R, Hattaway K, Míšková I, Beneš I, Kotěšovec F, Šrám R (1994): Czech-U.S. EPA health study: Assessment of personal and ambient air exposures to PAH and organic mutagens in the Teplice district of Northern Bohemia. Int J Environ Anal Chem 56:271-287.
47. Whyatt RM, Garte SJ, Cosma G, Bell DA, Jedrychowski W, Wahrendorf J, Randall MC, Cooper TB, Ottman R, Tang D, Tsai WY, Dickey CP, Manchester DK, Crofts F, Perera FP (1995): CYP1A1 messenger RNA levels in placental tissue as a biomarker of environmental exposure. Cancer Epidemiol Biomark Prev 4:147-153.
48. Yu MC, Skipper PL, Taghizadeh K, Tannenbaum SR, Chan KK, Henderson BE, Ross RK (1994): Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black and Asian men in Los Angeles, California. J Natl Cancer Inst 86:712-716.
49. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK (1993): Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821-1825.